Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1226 of 5804
-
New study monitors OBIZUR's safety in rare bleeding disorder
Disease control Recruiting nowAcquired hemophilia A (AHA) is a rare bleeding condition which prevents blood clotting. Acquired means that people are not born with this condition or have a family history of blood clotting conditions. People living with AHA can have sudden and severe bleeding. They also have lo…
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug zanzalintinib aims to shrink thyroid tumors before surgery
Disease control Recruiting nowTo look at the effectiveness of zanzalintinib, followed by surgery, in treating advanced thyroid cancer. The safety of this treatment will also be studied.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Fish skin used in groundbreaking gender surgery study
Symptom relief Recruiting nowBottom gender affirming surgery is one of the key steps towards aligning the physical appearance and gender identity in transgender women. This surgery not only helps in reducing gender dysphoria but also significantly improves the quality of life and psychological well-being of …
Sponsor: University Hospitals Cleveland Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New oral drug targets Hard-to-Treat cancers with missing gene
Disease control Recruiting nowThis is a first-in-human (FIH), multicenter, non-randomized, openlabel, phase 1 study of ABSK131 in patients with MTAP-Deficient Advanced/Metastatic Solid Tumors to evaluate the safety, tolerability, PK, and preliminary antitumor efficacy.
Phase: PHASE1 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis is a multicenter, open-label Phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary clinical efficacy of HY05350 for injection in patients with MSLN-positive advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a smartphone app help your heart and your memory after a procedure for AFib?
Disease control Recruiting now"Atrial fibrillation (AF) is known as the most common sustained arrhythmia observed in clinical situation. Pulse Field Ablation (PFA) is a recently introduced, effective atrial fibrillation (AF) ablation modality. PFA is safe for treating patients with AF. The "MANIFEST-17K" inte…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Stanford tests dream therapy under anesthesia for PTSD relief
Symptom relief Recruiting nowThe goal of this study is to test whether anesthesia-induced dreaming can help alleviate symptoms of PTSD in an (1) open-label trial (Phase I) and (2) double-blind, randomized controlled trial (Phase II) in a non-surgical setting. The investigators predict that inducing and susta…
Phase: PHASE2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Could sound waves boost brain health in Alzheimer's?
Symptom relief Recruiting nowTPS is a non-invasive therapeutic modality that uses focused, low-energy pulse stimulation to stimulate tissue regeneration and reduce inflammation. In the context of neurological disorders, it is hypothesized that TPS can modulate neuronal activity, enhance synaptic plasticity, …
Phase: PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 26, 2026 18:08 UTC
-
Blood test could revolutionize TB treatment monitoring
Knowledge-focused Recruiting nowTuberculosis (TB) is a leading infectious cause of death worldwide. Current strategies for monitoring TB treatment response are culture dependent and insensitive. New methods of assessing treatment response in vivo could inform new drug development and other treatment strategies.…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Blood 'Cleaning' may bring relief to High-Altitude sufferers
Symptom relief Recruiting nowThe study aims to explore the efficacy and safety of erythrocytapheresis in chronic mountain sickness
Phase: NA • Sponsor: Third Military Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Experimental enzyme injection aims to tame PKU's toxic amino acid
Disease control Recruiting nowThe primary objective of this clinical trial is to evaluate the safety and tolerability of single and multiple administrations of PL54 in patients aged 18-55 years. The key questions it aims to answer include: How safe and tolerable is PL54 in PKU patients following single and m…
Phase: PHASE1 • Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug KarXT aims to safely control bipolar mania over the long haul
Disease control Recruiting nowThis is a phase 3, open-label extension study to assess the long-term safety of KarXT for the treatment of mania or mania with mixed features in Bipolar-I disorder (BP-I) The primary objective of the study is to evaluate the long-term safety and tolerability of KarXT in the trea…
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a prescription stimulant help people stay in treatment for meth addiction?
Disease control Recruiting nowMethamphetamine use disorder (MUD) is becoming an increasing public health concern in Canada. While the evidence on the efficacy and safety of prescription psychostimulants for the treatment of MUD is promising, the knowledge on the maintenance therapy using stimulant agonist the…
Phase: PHASE2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
AI-Powered scans aim to predict breast cancer remission without surgery
Diagnosis Recruiting nowGoal of the observational study: Based on PET/MRI data it is possible to differentiate between complete and incomplete pathological remission after neoadjuvant systemic therapy in HER2-positive breast cancer patients. The main question it aims to answer are: Primary endpoint: …
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New psoriasis shot shows promise in early trial
Disease control OngoingThis is a multicenter, randomized, double-blinded, placebo-controlled, proof-of-concept study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of ORKA-001 in adult participants with moderate-to-severe plaque psoriasis.
Phase: PHASE2 • Sponsor: Oruka Therapeutics, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New IVIG treatment aims to boost platelets in bleeding disorder
Disease control Recruiting nowThis is a multicenter, prospective clinical trial evaluating the efficacy and safety of V-IMMUNE®, a 5% human normal immunoglobulin formulation administered intravenously, for the treatment of immune thrombocytopenia (ITP) in patients aged ≥1 year. The primary objective is to ass…
Phase: PHASE3 • Sponsor: On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New stent aims to clear long heart blockages safely
Disease control Recruiting nowThe purpose of the study is to assess the safety and efficacy of the Orsiro® Mission 48- mm Sirolimus-Eluting Coronary Stent System in the treatment of subjects with atherosclerotic lesion(s) \>36 mm and ≤ 44 mm in length (by visual estimate) in the native coronary arteries with …
Phase: NA • Sponsor: Teleflex • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Amniotic fluid test may predict kidney outcomes in unborn babies
Diagnosis Recruiting nowThe aim of this project is to validate a previously established amniotic fluid 98 peptide signature predictive of post-natal outcome in fetuses with congenital anomalies of the kidney and the urinary tract (CAKUT) in a "real" clinical context. It includes the feasibility of colle…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New hope for advanced cancer: combo therapy trial launches
Disease control Recruiting nowA Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors
Phase: PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug duo aims to slow kidney disease
Disease control OngoingThis study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific type of medication for kidney disease called SGLT2 inhibitor within 1 month before the study or have certain health conditions cannot take part in thi…
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC